Abstract
An impedimetric microfluidic–based biosensor was fabricated and investigated for quantification of the DNA sequence specific to chronic myelogenous leukemia (CML). The sensor chip was constructed by electrophoretic deposition of carboxyl-modified multiwalled carbon nanotubes (MWCNT) on the patterned (via wet chemical etching method) indium–tin–oxide (ITO) coated glass substrate. The MWCNT surface was immobilized with CML specific deoxyribonucleic acid probe, followed by sealing of the biochip with poly (dimethylsiloxane) microchannel for fluid control. This integrated miniaturized system was used to monitor complementary target DNA concentration by measuring the interfacial charge transfer resistance via hybridization. The presence of complementary DNA in buffer solution resulted in significant decrease in electrical conductivity of the interface thereby presenting a barrier for transport of the redox probe ions. Under optimal conditions, this microfluidic biochip exhibited good calibration range from 1fM to 1 μM and a response time of 60 s.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
